Frati P, Kyriakou C, Del Rio A, Marinelli E, Vergallo GM, Zaami S, Busardò FP (Ocak 2015). "Smart drugs and synthetic androgens for cognitive and physical enhancement: revolving doors of cosmetic neurology". Curr Neuropharmacol. 13 (1). ss. 5-11. doi:10.2174/1570159X13666141210221750. PMC4462043 $2. PMID26074739.
Chinthapalli K (Eylül 2015). "The billion dollar business of being smart". BMJ. Cilt 351. ss. h4829. doi:10.1136/bmj.h4829. PMID26370589.
Sattler, Sebastian; Wiegel, Constantin (25 Şubat 2013). "Cognitive Test Anxiety and Cognitive Enhancement: The Influence of Students' Worries on Their Use of Performance-Enhancing Drugs". Substance Use & Misuse. 48 (3). ss. 220-232. doi:10.3109/10826084.2012.751426. PMID23302063.
Weyandt LL, Oster DR, Marraccini ME, Gudmundsdottir BG, Munro BA, Zavras BM, Kuhar B (Eylül 2014). "Pharmacological interventions for adolescents and adults with ADHD: stimulant and nonstimulant medications and misuse of prescription stimulants". Psychol. Res. Behav. Manag. Cilt 7. ss. 223-249. doi:10.2147/PRBM.S47013. PMC4164338 $2. PMID25228824.
Clemow DB, Walker DJ (Eylül 2014). "The potential for misuse and abuse of medications in ADHD: a review". Postgrad. Med. 126 (5). ss. 64-81. doi:10.3810/pgm.2014.09.2801. PMID25295651.
Spencer RC, Devilbiss DM, Berridge CW (June 2015). "The Cognition-Enhancing Effects of Psychostimulants Involve Direct Action in the Prefrontal Cortex". Biol. Psychiatry. 77 (11). ss. 940-950. doi:10.1016/j.biopsych.2014.09.013. PMC4377121 $2. PMID25499957.
Bagot KS, Kaminer Y (Nisan 2014). "Efficacy of stimulants for cognitive enhancement in non-attention deficit hyperactivity disorder youth: a systematic review". Addiction. 109 (4). ss. 547-557. doi:10.1111/add.12460. PMC4471173 $2. PMID24749160.
Wood S, Sage JR, Shuman T, Anagnostaras SG (Ocak 2014). "Psychostimulants and cognition: a continuum of behavioral and cognitive activation". Pharmacol. Rev. 66 (1). ss. 193-221. doi:10.1124/pr.112.007054. PMC3880463 $2. PMID24344115.
Urban, KR; Gao, WJ (2014). "Performance enhancement at the cost of potential brain plasticity: neural ramifications of nootropic drugs in the healthy developing brain". Frontiers in Systems Neuroscience. Cilt 8. s. 38. doi:10.3389/fnsys.2014.00038. PMC4026746 $2. PMID24860437.
Gualtieri F, Manetti D, Romanelli MN, Ghelardini C (2002). "Design and study of piracetam-like nootropics, controversial members of the problematic class of cognition-enhancing drugs". Curr. Pharm. Des. 8 (2). ss. 125-38. doi:10.2174/1381612023396582. PMID11812254.
EFSA Panel on Dietetic Products, Nutrition and Allergies; European Food Safety Authority (EFSA), Parma, Italy (2011). "Scientific Opinion on the substantiation of health claims related to L-theanine from Camellia sinensis (L.) Kuntze (tea) and improvement of cognitive function (ID 1104, 1222, 1600, 1601, 1707, 1935, 2004, 2005), alleviation of psychological stress (ID 1598, 1601), maintenance of normal sleep (ID 1222, 1737, 2004) and reduction of menstrual discomfort (ID 1599) pursuant to Article 13(1) of Regulation (EC) No 1924/2006". EFSA Journal. 9 (6). s. 2238. doi:10.2903/j.efsa.2011.2238.KB1 bakım: Birden fazla ad: yazar listesi (link)
Fond G, Micoulaud-Franchi JA, Brunel L, Macgregor A, Miot S, Lopez R, Richieri R, Abbar M, Lancon C, Repantis D (Eylül 2015). "Innovative mechanisms of action for pharmaceutical cognitive enhancement: A systematic review". Psychiatry Res. 229 (1–2). ss. 12-20. doi:10.1016/j.psychres.2015.07.006. PMID26187342.
Gillies D; Sinn JKh; Lad SS; Leach MJ; Ross MJ (2012). "Polyunsaturated fatty acids (PUFA) for attention deficit hyperactivity disorder (ADHD) in children and adolescents". Cochrane Database Syst Rev. 7 (7). ss. CD007986. doi:10.1002/14651858.CD007986.pub2. PMID22786509.
Tan ML, Ho JJ, Teh KH (2012). "Polyunsaturated fatty acids (PUFAs) for children with specific learning disorders". Cochrane Database Syst Rev. Cilt 12. ss. CD009398. doi:10.1002/14651858.CD009398.pub2. PMID23235675.
Cooper RE, Tye C, Kuntsi J, Vassos E, Asherson P (2015). "Omega-3 polyunsaturated fatty acid supplementation and cognition: A systematic review and meta-analysis". J. Psychopharmacol. (Oxford). 29 (7). ss. 753-63. doi:10.1177/0269881115587958. PMID26040902.
Forbes SC, Holroyd-Leduc JM, Poulin MJ, Hogan DB (Aralık 2015). "Effect of Nutrients, Dietary Supplements and Vitamins on Cognition: a Systematic Review and Meta-Analysis of Randomized Controlled Trials". Can Geriatr J. 18 (4). ss. 231-45. doi:10.5770/cgj.18.189. PMC4696451 $2. PMID26740832.
Frati P, Kyriakou C, Del Rio A, Marinelli E, Vergallo GM, Zaami S, Busardò FP (Ocak 2015). "Smart drugs and synthetic androgens for cognitive and physical enhancement: revolving doors of cosmetic neurology". Curr Neuropharmacol. 13 (1). ss. 5-11. doi:10.2174/1570159X13666141210221750. PMC4462043 $2. PMID26074739.
Albertson TE, Chenoweth JA, Colby DK, Sutter ME (2016). "The Changing Drug Culture: Use and Misuse of Cognition-Enhancing Drugs". FP Essent. Cilt 441. ss. 25-9. PMID26881770.
Chinthapalli K (Eylül 2015). "The billion dollar business of being smart". BMJ. Cilt 351. ss. h4829. doi:10.1136/bmj.h4829. PMID26370589.
Giurgea C (1972). "[Pharmacology of integrative activity of the brain. Attempt at nootropic concept in psychopharmacology] ("Vers une pharmacologie de l'active integrative du cerveau: Tentative du concept nootrope en psychopharmacologie")". Actual Pharmacol (Paris) (Fransızca). Cilt 25. ss. 115-56. PMID4541214.
Sattler, Sebastian; Wiegel, Constantin (25 Şubat 2013). "Cognitive Test Anxiety and Cognitive Enhancement: The Influence of Students' Worries on Their Use of Performance-Enhancing Drugs". Substance Use & Misuse. 48 (3). ss. 220-232. doi:10.3109/10826084.2012.751426. PMID23302063.
Weyandt LL, Oster DR, Marraccini ME, Gudmundsdottir BG, Munro BA, Zavras BM, Kuhar B (Eylül 2014). "Pharmacological interventions for adolescents and adults with ADHD: stimulant and nonstimulant medications and misuse of prescription stimulants". Psychol. Res. Behav. Manag. Cilt 7. ss. 223-249. doi:10.2147/PRBM.S47013. PMC4164338 $2. PMID25228824.
Clemow DB, Walker DJ (Eylül 2014). "The potential for misuse and abuse of medications in ADHD: a review". Postgrad. Med. 126 (5). ss. 64-81. doi:10.3810/pgm.2014.09.2801. PMID25295651.
Spencer RC, Devilbiss DM, Berridge CW (June 2015). "The Cognition-Enhancing Effects of Psychostimulants Involve Direct Action in the Prefrontal Cortex". Biol. Psychiatry. 77 (11). ss. 940-950. doi:10.1016/j.biopsych.2014.09.013. PMC4377121 $2. PMID25499957.
Bagot KS, Kaminer Y (Nisan 2014). "Efficacy of stimulants for cognitive enhancement in non-attention deficit hyperactivity disorder youth: a systematic review". Addiction. 109 (4). ss. 547-557. doi:10.1111/add.12460. PMC4471173 $2. PMID24749160.
Wood S, Sage JR, Shuman T, Anagnostaras SG (Ocak 2014). "Psychostimulants and cognition: a continuum of behavioral and cognitive activation". Pharmacol. Rev. 66 (1). ss. 193-221. doi:10.1124/pr.112.007054. PMC3880463 $2. PMID24344115.
Urban, KR; Gao, WJ (2014). "Performance enhancement at the cost of potential brain plasticity: neural ramifications of nootropic drugs in the healthy developing brain". Frontiers in Systems Neuroscience. Cilt 8. s. 38. doi:10.3389/fnsys.2014.00038. PMC4026746 $2. PMID24860437.
Gualtieri F, Manetti D, Romanelli MN, Ghelardini C (2002). "Design and study of piracetam-like nootropics, controversial members of the problematic class of cognition-enhancing drugs". Curr. Pharm. Des. 8 (2). ss. 125-38. doi:10.2174/1381612023396582. PMID11812254.
Fond G, Micoulaud-Franchi JA, Brunel L, Macgregor A, Miot S, Lopez R, Richieri R, Abbar M, Lancon C, Repantis D (Eylül 2015). "Innovative mechanisms of action for pharmaceutical cognitive enhancement: A systematic review". Psychiatry Res. 229 (1–2). ss. 12-20. doi:10.1016/j.psychres.2015.07.006. PMID26187342.
Gillies D; Sinn JKh; Lad SS; Leach MJ; Ross MJ (2012). "Polyunsaturated fatty acids (PUFA) for attention deficit hyperactivity disorder (ADHD) in children and adolescents". Cochrane Database Syst Rev. 7 (7). ss. CD007986. doi:10.1002/14651858.CD007986.pub2. PMID22786509.
Tan ML, Ho JJ, Teh KH (2012). "Polyunsaturated fatty acids (PUFAs) for children with specific learning disorders". Cochrane Database Syst Rev. Cilt 12. ss. CD009398. doi:10.1002/14651858.CD009398.pub2. PMID23235675.
Cooper RE, Tye C, Kuntsi J, Vassos E, Asherson P (2015). "Omega-3 polyunsaturated fatty acid supplementation and cognition: A systematic review and meta-analysis". J. Psychopharmacol. (Oxford). 29 (7). ss. 753-63. doi:10.1177/0269881115587958. PMID26040902.
Forbes SC, Holroyd-Leduc JM, Poulin MJ, Hogan DB (Aralık 2015). "Effect of Nutrients, Dietary Supplements and Vitamins on Cognition: a Systematic Review and Meta-Analysis of Randomized Controlled Trials". Can Geriatr J. 18 (4). ss. 231-45. doi:10.5770/cgj.18.189. PMC4696451 $2. PMID26740832.